Showing results (2231-2240 of 2,895) with videos related to

Sort By:
Pageof 290
International Archives of Allergy and Immunology|March 14, 2015
Component-resolved IgE profiles in Austrian patients with a convincing history of peanut allergyDaniela Ackerbauer, Merima Bublin, Christian Radauer, et al.
Molecular Neurobiology|March 14, 2026
The Interferon-miR-146a-5p-Stat1/Nrf2 Pathway Mediates LRRK2-R1441G-induced M1 over M2 Microglia ActivationLishan Lin, Junfeng Luo, Xiantao Wang, et al.
Allergy|October 6, 2020
Identification of Pru du 6 as a potential marker allergen for almond allergyStefan Kabasser, Christine Hafner, Sharon Chinthrajah, et al.
Journal of Clinical Immunology|April 12, 2005
Lower CD4+ T lymphocyte nadirs may indicate limited immune reconstitution in HIV-1 infected individuals on potent antiretroviral therapy: analysis of immunophenotypic marker results of AACTG 5067Ronald D'Amico, Yijun Yang, Donna Mildvan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 20, 2001
Monovalent fusion proteins of IgE mimotopes are safe for therapy of type I allergyE Ganglberger, Barbara Sponer, I Schöll, et al.
Molecular Cell|July 5, 2011
Integrative regulatory mapping indicates that the RNA-binding protein HuR couples pre-mRNA processing and mRNA stabilityNeelanjan Mukherjee, David L Corcoran, Jeffrey D Nusbaum, et al.
Journal of Cell Science|February 15, 2012
Rapsyn mediates subsynaptic anchoring of PKA type I and stabilisation of acetylcholine receptor in vivoKyeong-Rok Choi, Marco Berrera, Markus Reischl, et al.
Frontiers in Immunology|January 24, 2022
Cleavage-Mediated Regulation of Myd88 Signaling by Inflammasome-Activated Caspase-1Monika Avbelj, Iva Hafner-Bratkovič, Duško Lainšček, et al.
The Journal of Investigative Dermatology|January 19, 2006
Increased expression of CTLA-4 in malignant T-cells from patients with mycosis fungoides -- cutaneous T cell lymphomaHenry K Wong, Adam J Wilson, Heather M Gibson, et al.
Infection|January 1, 1994
Prevalence of fluoroquinolone resistance in Europe. Study Group 'Bacterial Resistance' of the Paul-Ehrlich-Society for Chemotherapy e. VM Kresken, D Hafner, H Mittermayer, et al.
Pageof 290